Fritextsökning
Innehållstyper
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
LEO Pharma - International Clinical Trial Manager
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Ny definition av smärta välkomnas
Den nya definitionen kan enligt en smärtläkare bidra till att patienter slipper mötas av okunniga utlåtanden.
-
Ny kunskap om sällsynt grundämne
Forskare från Göteborgs universitet har lyckats skapa små mängder av världens mest sällsynta grundämne.
-
Fullt upp för konsultföretag när nya medtechregler införs
Den nya medicintekniska förordningen MDR har skapat en stor efterfrågan på konsulttjänster – en efterfrågan som ser ut att hålla i sig.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Double the channels for half the work
The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Globalt uttalande
Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.